The largest database of trusted experimental protocols

6 protocols using zb 2307

1

Chemokine Receptor Expression in Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tissue sections were obtained from the Department of Pathology of the First Affiliated Hospital of Guangxi Medical University. IHC assay was performed using a universal two-step IHC kit (PV-9000, ZSGB-BIO, Biotech, Beijing, China) following the manufacturer’s protocols. The primary antibodies against CCR1 (DF2710, Affinity, Jiangsu, China), CCR5 (AF6339, Affinity, Jiangsu, China), and CCR7 (AF5293, Affinity, Jiangsu, China), as well as peroxidase-conjugated goat antirat IgG (ZB-2307, ZSGB-BIO, Beijing, China) were used to perform the IHC assay. Tumor sections were incubated overnight with primary antibodies at 4° C. The primary antibody titer was configured according to the IHC concentration recommended by the manufacturer (CCR1, 1:200; CCR5, 1:300; CCR7, 1:100).
+ Open protocol
+ Expand
2

Investigating Pyroptosis Regulatory Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
J774A.1 cells, a mouse monocyte/macrophage cell line, were propagated in RPMI-1640 medium (Gibco) supplemented with 10% fetal bovine serum (FBS) at 37°C with 5% CO2.
T. pyogenes (strain 0912) was cultured in Martin broth medium with 10% fetal bovine serum under aerobic conditions.
Primary antibodies included rabbit monoclonal anti-GSDMD (ab209845, Abcam), rat monoclonal anti-caspase-1(BL-645102, Biolegend), rabbit monoclonal anti-caspase-11 (ab180673, Abcam), mouse monoclonal anti-NLRP3(AG-20B-0014, Adipogen), and mouse anti-GAPDH antibody (GTX627408, GeneTex). Secondary antibodies included horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (ZB-2305, ZSGB-BIO), HRP-conjugated goat anti-rabbit IgG (ZB-2301, ZSGB-BIO) and HRP-conjugated goat anti-rat IgG secondary antibody (ZB-2307, ZSGB-BIO).
Chemicals included VX-765 (Capase-1 inhibitor) (S2228, Selleck), MCC950 (NLRP3 inhibitor) (S8930, Selleck), Necrostatin-1 (Nec-1) (receptor-interacting serine/threonine protein kinase 1 [RIP1] inhibitor) (A4213, APExBIO), Necrosulfonamide (NSA) (mixed lineage kinase domain-like protein [MLKL] and GSDMD inhibitor) (B7731, APExBIO), and Wedelolactone (Wed) (caspase-11 and NLRP3 inhibitor) (HY-N0551, MedChemExpress).
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of DAT, D2R, and TH

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining to determine levels of DAT and D2R proteins and TH activity was conducted with striatal slices. To prepare for staining, the slices were prewashed in PBS (0.01 M, pH 7.4) three times for 5 min each, then sequentially treated with 0.2% Triton X-100 in PBS for 5 min and with 0.3% H2O2 in PBS for 10 min, and washed in PBS three times for 5 min each, all at room temperature. Slices were initially incubated with 10% normal goat serum for 10 min (or normal donkey serum for TH measurement), then incubated for 20 h at 4°C with the primary antibodies (D2R antibody AB5084P, Millipore, CA, USA, 1:200 dilution; DAT antibody MAB369, Millipore, CA, USA, 1:100 dilution; TH antibody T1299, Sigma, CA, USA, 1:10,000 dilution), washed three times in PBS, and incubated for 60 min at 37°C with the secondary antibodies (anti-rabbit antibody PV-6001, ZSGB-BIO, CA, USA; anti-rat antibody ZB-2307, ZSGB-BIO, CA, USA; anti-mouse antibody PK4002, Vector, CA, USA). Slices were then washed five times for 3 min each in PBS, and incubated in 100 μL of 3,3′-diaminobenzidine tertrahydrochloride (DAB) for 3 min. The slices immunostained for TH were incubated in the ABC (VECTASTAIN ABC kit, ZSGB-BIO, Beijing, China) reagent for 30 min at 37°C and washed five times for 3 min each in PBS prior to the DAB treatment. Final wash of the slices was done in distilled water.
+ Open protocol
+ Expand
4

Periploca forrestii Schltr Therapeutic Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Periploca forrestii Schltr were obtained from Yulin, Guangxi, China. A voucher specimen was deposited in the Medicinal Herb Garden, Guilin Medical University. Periplocin was purchased from General Administration of Quality Supervision, Inspection and Quarantine China. Oxazolone was purchased from Alfa Aesar Thermo Fisher. Hydrocortisone (HC), α-MEM, MTT, and phosphatase inhibitors were purchased from Beijing Solarbio. Lipopolysaccharide (LPS, Escherichia) was purchased from Sigma-Aldrich, and fetal calf serum was purchased from Equus Biotechnology. M-CSF was purchased from PeproTech, USA. Protease inhibitor cocktail was from MCE, USA. ELISA kits for IgE, IgG1, IgG2a, TNF-α, MCP-1, IL-6, IL-4, IL-10, and IL-22 were purchased from Thermo Fisher. Antibodies for NOS2 (sc-7271), STAT3 (sc-8019), and MCP-1 (sc-52701) were purchased from Santa Cruz Biotechnology, Arg1 antibody (CST-93668) was obtained from Cell Signaling Technology, CD163 (ab182422) antibody was purchased from Abcam, p-STAT3 Tyr705 antibody (Tyr705-11045) was purchased from Signalway Antibody, and GAPDH antibody (60004-1-Ig) was purchased from Proteintech. Horseradish peroxidase- (HRP-) conjugated rabbit, mouse, or rat IgG secondary antibodies (ZB-2301, ZB-2305, and ZB-2307) were purchased from ZSGB-BIO, China. Primers were synthesized from Invitrogen.
+ Open protocol
+ Expand
5

Quantification of Membrane Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The membrane protein was extracted and quantificated according to the instructions of kits (P0033 and P0009, Beyotime). Samples (each 20 ng) were then separated on 10% SDS- polyacryamide gel and transferred onto a polyvinylidene difluoride (PVDF) membrane (Millipore, MA, USA). The PVDF membranes were blocked with the blocking buffer (5% nonfat milk in Tris-buffer saline containing 0.05% Tween-20,TTBS) and incubated with MOR antibody (abcam, ab51140) or β-actin antibody (sc-130656, Santa Cruz), diluted 1:1000 in blocking buffer, at 4℃ overnight. After washing with TTBS, the membrane were then probed with horseradish peroxidase (HRP)-conjugated second (ZB-2307, ZSGB-BIO) antibody diluted 1:2000 in blocking buffer, for 2h at room temperature. Secondary antibody binding was detected by reaction with ECL plus reagent (GE Healthcare, Piscataway, NJ, USA). Gel-Pro analyzer software was applied to analyze the optical density of the bands. The relative expression of MOR protein = optical density value of each group/density value of the sham group × 100%.
+ Open protocol
+ Expand
6

Protein Expression Analysis in Mouse SDH

Check if the same lab product or an alternative is used in the 5 most similar protocols
After the mice were anesthetized by intraperitoneally injecting 0.5% pentobarbital sodium, the lumbar level SDH was removed on a ice surface. The tissue was lysed for 1 h at 4 °C by the RIPA lysis buffer added with the protease inhibitor phenylmethylsulfonyl fluoride after homogenization. Protein concentration quantitation was performed via the BCA quantitation method. Protein samples were electrophoresed on 10% SDS-PAGE gels and then transferred to nitrocellulose membranes. The membranes were blocked in 5% skim milk at about 22-26 °C for 1 h. The membranes were incubated in the primary antibodies at 4 °C for 12 h: rat anti-CSF1R primary antibody (271294; 1:1000; Abcam); and mouse anti-β-actin primary antibody (TA-09; 1:1000; ZSGB-BIO). Subsequently, the secondary antibodies were applied to bind the primary antibodies at about 22-26 °C for 1 h: horseradish peroxidase (HRP)-conjugated goat anti-rat antibody (ZB-2307; 1:2000; ZSGB-BIO); and HRPconjugated goat anti-mouse antibody (ZB-2305; 1:2000; ZSGB-BIO). The membranes were exposed using the chemiluminescent HRP substrate (P90720, Millipore, USA). The Image J software was applied to calculate the quantitative analysis of the gray value of the membranes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!